Made from actual food
Real photographs from current product development.
Why this round exists
Israel validates the model. The US scales it.
Capital strategy
$180.5K → $189.5KCapital is split into two tranches. The second tranche follows only after the pilot batch is delivered and the first retail sell-through gate is reached.
Validation objective
≥30Target units per store per week, followed by a ≥40% trial-to-repeat target before the next institutional round.
Where we are now
A live snapshot of the project’s current position and next measurable gate.
CURRENT STAGE
In progressPre-pilot
& R&D
& R&D
Current focusShelf-life & pilot preparation
Funding raised$12,000
Patent statusPatent pending
NEXT MILESTONE
10K unitsPilot batch delivered
Plus kosher certification and the first measurable retail sell-through gate.
Raised funds at work
How the first $12,000 is being converted into product and infrastructure.
Raised$12K
Spent$4.2K
Available$7.8K
Spent 35%Available 65%
Laboratory work
Product R&D and technical validationDigital infrastructure
Technical website specialist salaryLatest achievements
Evidence added as the project moves from prototype to pilot.
Product format and prototypes developed
Compact savoury crunchy bites created from real food ingredients.
Technology entered patent process
Protection initiated for the multi-stage production approach.
1,300 people joined the waitlist
Organic response generated from a single cold-audience post.
National distributor LOI secured
A commercial route into major Israeli supermarket chains.
Eight stores committed to pilot
Politzer supermarkets in the Caesarea region reserved for validation.
Pilot preparation underway
Shelf-life work, regulatory preparation and co-packer selection.
Three demand signals
Money, organic attention and commercial commitments point in the same direction.
Committed revenue
19 paid preorders, $82 average order value and 5.4% conversion from 350 crowdfunding visitors.
Waitlist sign-ups
Generated in two days from one unpaid post to a cold 115K-member Facebook group.
Distribution path
Signed LOI with an Israeli national distributor, plus shelf commitment from eight Politzer supermarkets.
From attention to real demand
Five independent evidence points collected across research, audience response and paid demand.
This is an evidence path, not a single attributed conversion funnel: the research responses, Facebook audience and crowdfunding visitors came from different validation activities.
Compare the alternatives
Select a category to see where The Real Meal creates a different proposition.
Protein bars
Quest, RXBAR, KIND
CrunchyYes
SavouryNo
Real ingredientsMixed
No preparationYes
Complete mealUsually no
Additional validation
- 95% of tasters stated intent to purchase regularly.
- Price range of $6–8 validated across 2,500 responses.
- Samples reached military procurement contacts for internal review.
Why it can retain
- Crunchy and savoury, reducing sweet flavour fatigue.
- Real ingredients instead of powder or liquid.
- No preparation, water, shaker, cutlery or refrigeration.
Milestone-gated roadmap
Select a stage to inspect its deliverables and KPI.
MONTH 0–3Gate: pilot delivered + kosher certified
Setup & pilot batch
Deliver a 10K-unit pilot batch, complete kosher certification, begin 12-month real-time shelf-life validation and select a co-packer.
Explore an investment scenario
Adjust the assumptions to see a simplified SAFE illustration based on the $3M valuation cap.
Indicative ownership at cap0.17%
Illustrative value at exit$83K
Ownership after dilution0.083%
Illustrative multiple16.7×
Illustrative only, not a promise or forecast. The model assumes conversion at the $3M cap and applies the selected dilution mechanically. Actual SAFE conversion, ownership, taxes, liquidation preferences and investor return may differ materially. The investment may be lost entirely.
Use of funds
Two tranches released against operating milestones.
TRANCHE 1 · MONTHS 1–4
$180.5KPilot setup
Runway$48K
Pilot batch$45K
R&D$35K
Marketing$35K
Regulatory$17.5K
TRANCHE 2 · MONTHS 5–9
$189.5KCommercial scale-up
Runway$80K
Production$52K
Marketing$50K
Regulatory$7.5K
Early-stage investment is high risk. SAFE illustrations are not promises of return. Investors may lose their entire investment. Financial and legal materials require final verification before publication.
Key risks and how we address them
The project is early-stage. These are the execution risks investors should understand.
Shelf-life validation
Long-term stability and final product characteristics are still being validated.
Mitigation: accelerated testing alongside 12-month real-time validation and laboratory work.
Production economics
Final COGS and gross margin depend on batch size, co-packer terms and production learning.
Mitigation: staged pilot, multiple co-packers in the pipeline and capital gates before scale-up.
Regulatory approvals
Commercial launch depends on certification, labelling and country-specific compliance.
Mitigation: Israeli kosher and Ministry of Health work, plus early US regulatory preparation.
Repeat purchase
Retail repeat behaviour has not yet been proven at commercial scale.
Mitigation: measurable ≥40% trial-to-repeat gate before the next institutional round.
Financing execution
Delays in financing may shift production, certification and market-entry timing.
Mitigation: two-tranche structure and no deployment into the next stage before prior gates are met.
Market-entry assumptions
Demand signals are promising but do not guarantee US or national retail adoption.
Mitigation: Israel as a data hub before US scaling and channel expansion.
Let’s discuss the round.
Request the full investor deck, financial model and product samples.